About Us
Medical Blog
  • Abbott to Acquire St. Jude Medical for $25 Billion

    A burst of potential acquisitions and consolidations occurred on April 28th in the medical device world, the largest being Abbott Laboratories' deal to acquire St. Jude Medical Inc.  The deal is for $25 billion dollars and would bring together two of the leaders in cardiac-related medical devices.  It allows Abbott to boost its medical-device sector to compete with competitors Medtronic PLC ...
  • FDA Proposes Ban on Electrical Stimulation Devices for Aggressive or Self-Injurious Behavior

    On April 25, the U.S. Food and Drug Administration published a proposed rule banning electrical stimulation devices (ESDs) used to treat aggressive or self-injurious behavior. ESDs have been used to reduce or eliminate self-injurious or aggressive behavior by applying an electric shock to the skin.  According to the proposal, FDA determined that ESDs "present an unreasonable and substantial ...
  • First U.S. Implant of St. Jude’s First-to-Market “CRT-D”

    St. Jude Medical, Inc. recently announced the U.S. launch and the first U.S. implant of its Quadra Assure MP™ cardiac resynchronization therapy defibrillator (CRT-D).  The Quadra Assura MP™ features St. Jude Medical's first-to-market  MultiPoint™ Pacing (MPP) technology.  The device received CE Mark Approval for MRI Compatibility in December 2015 and the MPP technology received U ...
Conferences
  • Jun

    14

    MD&M East

    Jacob K. Javits Convention Center

    June 14 - 16, 2016

    New York, NY

    For over 30 years, MD&M East has been your trusted resource for every aspect of medical device development. No matter where you are in the product development life cycle, you’ll find the thought-leadership, education, suppliers, and resources you require to bring your medical device from paper to patent.

  • Sep

    18

    Vascular InterVentional Advances (VIVA)

    Wynn Hotel

    September 18 - 22, 2016

    Las Vegas, NV

    VIVA is the premier global, multidisciplinary course for vascular intervention and medicine. For the past 11 years, VIVA has defined excellence in professional education by offering attendees an innovative, provocative, and balanced educational experience, enhanced by the use of technology and electronic interaction between participants and faculty experts.

  • Oct

    29

    Transcatheter Cardiovascular Therapeutics

    Walter E. Washington Convention Center

    October 29 - November 2, 2016

    Washington, DC

    Transcatheter Cardiovascular Therapeutics (TCT) is the world’s largest and most important educational meeting specializing in interventional cardiovascular medicine. For over 25 years, TCT has been the center of cutting-edge educational content, showcasing the latest advances in current therapies and clinical research.